However, when kidney function becomes compromised, this safety profile changes dramatically, making it worth having a deeper conversation with your healthcare provider
#PositiveBehaviourSupport #PBS #ClinicalReasoning #NDISProfessionals #BehaviourSupport To view or add a comment, sign in What happens after GLP-1 treatment ends
Vitam Horm 84: 81-110, 2010
Regular provider review ensures continued appropriateness and detects potential interactions or adverse effects
If you want a broader overview of the molecule itself, our guide on What Is in Glutathione is a helpful companion read
Available from Accessed 1 Mar 2023 Danne T, Garg S, Peters AL et al (2019) International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors